- $22.90bn
- $24.40bn
- $5.19bn
- 95
- 21
- 76
- 69
Annual income statement for Veralto, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,348 | 4,700 | 4,870 | 5,021 | 5,193 |
| Cost of Revenue | |||||
| Gross Profit | 2,510 | 2,713 | 2,760 | 2,901 | 3,105 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,397 | 3,659 | 3,758 | 3,896 | 3,985 |
| Operating Profit | 951 | 1,041 | 1,112 | 1,125 | 1,208 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 950 | 1,047 | 1,113 | 1,096 | 1,086 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 724 | 861 | 845 | 839 | 833 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 724 | 861 | 845 | 839 | 833 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 724 | 861 | 845 | 839 | 833 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3 | 3.5 | 3.46 | 3.48 | 3.37 |
| Dividends per Share |